• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Orthopedic Surgery

Percutaneous transforaminal endoscopic discectomy non-inferior to open microdisctectomy

byIshita AggarwalandAlex Chan
March 21, 2022
in Orthopedic Surgery, Surgery
Reading Time: 3 mins read
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Share on FacebookShare on TwitterShare on LinkedIn

1. Percutaneous transforaminal endoscopic discectomy (PTED) was non-inferior to open microdiscectomy in reduction of leg pain

Evidence Rating Level: 1 (Excellent)

Study Rundown: Sciatica is a common health problem. Most frequently caused by lumbar disc herniation, sciatica is typically characterized by radiating leg pain starting from the low back, sometimes accompanied by sensory or motor deficits. In most people, sciatica has a favourable natural course. However, when conservative treatment fails or progressive neurological deficits develop, surgery may be indicated. The standard procedure for treating lumbar disc herniation is open microdiscectomy. However, other surgical techniques that are less invasive in nature have also been developed. One of these techniques is percutaneous transforaminal endoscopic discectomy (PTED). PTED is expected to lead to shorter hospital admission, faster recovery time and less postoperative back pain because general anesthesia is not used, paraspinal muscles are not detached from their insertion points, and bony anatomy is not changed. This randomized controlled trial aimed to assess whether PTED is non-inferior to conventional open microdiscectomy in reduction of leg pain caused by lumbar disc herniation. Participants included a total of 613 patients aged 18-70 with at least six weeks of radiating leg pain caused by lumbar disc herniation. Patients were randomized in a one to one ratio to PTED or open microdiscectomy. The primary outcome measure was self-reported leg pain measured by a 0-100 visual analogue scale at 12 months. At 12 months, patients who were randomized to PTED had a statistically significantly lower visual analogue scale score for leg pain (median 7.0, interquartile range 1.0-30.0) compared with patients randomized to open microdiscectomy (16.0, 2.0-53.5) (between group difference of 7.1, 95% confidence interval 2.8 to 11.3). It was concluded that PTED was non-inferior to open microdiscectomy in reduction of leg pain.

Click here to read the study in The BMJ

Relevant Reading: Surgery versus conservative care for persistent sciatica lasting 4 to 12 months

In-Depth [Randomized Controlled Trial]: This study was conducted at four general hospitals in the Netherlands in patients with sciatica caused by lumbar disc herniation. Patients were eligible if they had an indication for surgery, meaning at least six weeks of excessive radiating leg pain with no evidence of clinical improvement on conservative therapy. Other inclusion criteria were age between 18 and 70 years, confirmation of a nerve root compression by a lumbar disc herniation on magnetic resonance imaging, and sufficient knowledge of the Dutch language to complete forms and follow instructions. Exclusion criteria were previous surgery at the same or adjacent disc level, cauda equina syndrome, isthmic or degenerative spondylolisthesis, pregnancy, severe comorbid medical or psychiatric disorder, severe caudal or cranial sequestration of disc fragments, contraindication for surgery, and moving abroad on short notice. Participants were randomly assigned to receive either PTED or open microdiscectomy. The primary outcome was the improvement in leg pain at one year, as measured with a visual analogue scale ranging from 0 to 100 with higher scores indicating more leg pain. Secondary outcomes were functional status as measured with the Oswestry Disability Index, back pain, quality of life, physical and mental health as measured with the short form 36 (SF-36), and self-perceived recovery from symptoms, recovery from leg pain, satisfaction with treatment, and change in symptoms. Between February 2016 and April 2019, 613 patients were enrolled in the study. Of the 304 patients randomized to PTED, 286 (94%) received the intervention. Of the 309 patients randomized to open microdiscectomy, 244 (79%) underwent surgery. At 12 months follow-up, the primary outcome was available for 532 (87%) of the randomized patients. The median visual analogue scale for leg pain showed a similar improvement in leg pain in both groups following surgery. In the first three months, mean differences in reduction of leg pain between the groups were small. At six, nine, and 12 months, mean differences in favour of PTED increased. At 12 months’ follow-up, the mean between group difference in leg pain was 7.1 (95% confidence interval 2.8 to 11.3) in favour of PTED. In general, mean differences in secondary outcomes between both groups were small in the first three months and increased in favour of PTED at six, nine, and 12 months. These results suggest that PTED can be considered as an effective alternative to open microdiscectomy in treating sciatica.

RELATED REPORTS

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: orthopedic surgerySurgery
Previous Post

2 Minute Medicine Rewind Mar 21, 2022

Next Post

Kratom use disorder and withdrawal may be common in the United States

RelatedReports

Two pieces of fabric showing stitching techniques with surgical tools in the foreground, indicating procedures for hernia repair.
Gastroenterology

Induction with remimazolam (Byfavo) for patients undergoing laparoscopic gastrointestinal surgery may reduce post-operative delirium compared with propofol

October 20, 2026
Robotic surgical instruments with surgical mesh and sutures, indicating a procedure for hernia repair.
Gastroenterology

Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy

October 6, 2026
A bag of enteral nutrition, a tube, and a graphic representation of the pancreas, suggesting early enteral nutrition in surgical patients.
Imaging and Intervention

Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear

September 15, 2026
A graphic featuring a heart, kidney, bladder, stethoscope, and an ultrasound machine, arranged in a flower-like design on a light blue background.
Weekly Rewinds

2 Minute Medicine Rewind September 14, 2026

September 14, 2026
Next Post
Galcanezumab reduces the frequency of episodic cluster headaches

Kratom use disorder and withdrawal may be common in the United States

New genetic link in pulmonary arterial hypertension holds therapeutic promise

Valoctocogene roxaparvovec gene therapy efficacious for hemophilia A treatment

Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Rucaparib compared to standard-of-care chemotherapy showed promising clinical and safe response to treat BRCA1 or BRCA2 mutated, relapsed ovarian carcinoma

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.